Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200043077/composite

$

44.51

Change

0.00 0.00%

Volume

Volume 30,493

Dec 2, 2021, 4:13 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Today's close

$ 44.42

$ 44.51

Change

+0.09 +0.20%

Day low

Day high

$43.09

$44.76

Open
Open: 44.35

52 week low

52 week high

$43.09

$93.94

Open

Market cap

$5.42B

Average volume

460,368

P/E ratio

334.66

Rev. per Employee

$1.15M

EPS

0.13

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/dnli

MarketWatch News on DNLI

  1. 4 Beaten-Down Biotech Stocks That Could Take Off

    3:07 p.m. Nov. 17, 2021

    - Barron's Online

  2. Denali Therapeutics started at outperform with $85 stock price target at Oppenheimer

    6:16 a.m. Sept. 21, 2021

    - Tomi Kilgore

  3. Biogen's Alzheimer's Drug Is Approved by the FDA

    1:02 p.m. June 7, 2021

    - Barron's Online

  4. Don’t Expect Amazon Prime Day to Move the Stock

    7:26 a.m. June 2, 2021

    - Barron's Online

  5. The FDA's Biogen Decision Will Cause Waves Across Biotech

    8:20 p.m. June 1, 2021

    - Barron's Online

  6. Denali Therapeutics started at buy with $70 stock price target at UBS

    8:03 a.m. May 18, 2021

    - Tomi Kilgore

  7. Biotech stocks are a buy — especially these 18 picks

    1:02 p.m. March 13, 2021

    - Michael Brush

  8. The 12 Most Overpriced Stocks in America

    7:48 a.m. Dec. 28, 2020

    - Barron's Online

  9. Denali down 10% on pause in neurological drug

    4:53 p.m. June 9, 2020

    - MarketWatch.com

  10. Panic Takes Hold

    7:39 p.m. March 12, 2020

    - Barron's Online

  11. Denali Therapeutics upgraded to outperform from neutral at Wedbush

    8:05 a.m. Feb. 28, 2020

    - Tomi Kilgore

  12. Denali Therapeutics started at hold with $26 stock price target at Stifel Nicolaus

    7:40 a.m. Feb. 19, 2020

    - Tomi Kilgore

  13. Denali Therapeutics started at neutral with $19 stock price target at Wedbush

    7:22 a.m. Sept. 26, 2019

    - Tomi Kilgore

  14. Denali Therapeutics started at buy with $35 stock price target at Instinet

    7:35 a.m. Sept. 13, 2019

    - Tomi Kilgore

  15. Jeffrey Epstein’s Investing Lagged Behind the Market

    12:23 p.m. July 17, 2019

    - Barron's Online

  16. Harry Boxer’s 4 stocks running on earnings

    1:42 p.m. March 14, 2019

    - Harry Boxer

  17. Denali Therapeutics started at market perform at Raymond James

    7:57 a.m. Nov. 30, 2018

    - Tomi Kilgore

  18. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/dnli

Other News on DNLI

  1. 10-Q: DENALI THERAPEUTICS INC.

    4:13 p.m. Nov. 4, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  2. Ron Baron Comments on Denali Therapeutics

    3:07 p.m. Oct. 26, 2021

    - GuruFocus.com

  3. Ron Baron's Baron Growth Fund 3rd-Quarter Letter

    2:49 p.m. Oct. 26, 2021

    - GuruFocus.com

  4. Warning: DNLI is at high risk of performing badly

    4:39 a.m. Oct. 21, 2021

    - Seeking Alpha

  5. New Strong Sell Stocks for October 12th

    11:00 a.m. Oct. 12, 2021

    - Zacks.com

  6. Denali/Sanofi ALS candidate granted FDA Fast Track status

    4:18 p.m. Oct. 6, 2021

    - Seeking Alpha

  7. Loading more headlines...
/news/pressrelease/company/us/dnli

Press Releases on DNLI

  1. FRP Tank Market to Witness Growth Acceleration During 2020-2025

    11:59 a.m. Aug. 31, 2021

    - Market Insight Reports

  2. FRP Tank Market to Experience Rebound in Sales post COVID-19

    6:09 a.m. Aug. 19, 2021

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.